Stocks in play: Exro Technologies Inc.

Has entered into an amended agreement with Eight Capital and Raymond James Ltd., as lead underwriters and joint bookrunners on behalf of a syndicate of underwriters, pursuant to which the Underwriters have now agreed to purchase, on a bought deal basis, 10,938,000 units of the Company at a price of $1.60 per Unit for aggregate gross proceeds of $17,500,800. Each Unit consists of one common share in the capital of the Company, and one half of one common share purchase warrant. Each Warrant is exercisable into one common share of the Company at an exercise price of $2.00 for a period of 36 months from the closing of the Offering. Exro Technologies Inc. shares T.EXRO are trading unchanged at $1.93.

Read:

• Optimism on the Rise Thanks to New Developments in Oncology in the Fight Against Cancer

• Double-Digit Growth in Global Cancer Immunotherapy Market to Drive Advancements Ahead of 2030

• Wave of Massive ESG Investments Triggering Major Developments in Mining of Critical Minerals

• Investment in New Plant-Based Alternative Meat Products Ramps Up Into 2022

• New Treatments Needed as Breast Cancer Was Leading Killer of Female Cancer Patients in 2019